Drugs Similar to LANREOTIDE ACETATE

LANREOTIDE ACETATE

Related medications based on brand, generic name, substance, active ingredients.

By Brand

Drugs with the same brand name or brand family

LANREOTIDE ACETATE LANREOTIDE ACETATE
60 mg/0.2 ml Injection
CIPLA USA INC. FDA Rx Only

Lanreotide Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). Lanreotide Injection is available as sterile, ready-to-use, single-dose prefilled syringes containing lanreotide acetate supersaturated bulk solution of 24.6% w/w lanreotide base. Each syringe contains: LANREOTIDE ACETATE LANREOTIDE ACETATE LANREOTIDE ACETATE 60 mg/0.2 mL 90 mg/0.3 mL 120 mg/0.5 mL Lanreotide acetate 74.9 mg 108.2 mg 141.5 mg Acetic Acid q.s. q.s. q.s. Water for injection 196.8 mg 284.5 mg 372.1 mg Total Weight 273.9 mg 395.9 mg 517.8 mg Lanreotide acetate is a synthetic cyclical octapeptide analog of the natural hormone, somatostatin. Lanreotide acetate is chemically known as [cyclo S-S]-3-(2-naphthyl)-D-alanyl-L-cysteinyl-L- tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, acetate salt. Its molecular weight is 1096.34 (base) and its amino acid sequence is: The Lanreotide Injection in the prefilled syringe is a white to pale yellow, semi-solid formulation. structure

LANREOTIDE ACETATE LANREOTIDE ACETATE
60 mg/0.2 ml Injection
EXELAN PHARMACEUTICALS, INC. FDA Rx Only

Lanreotide Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). Lanreotide Injection is available as sterile, ready-to-use, single-dose prefilled syringes containing lanreotide acetate supersaturated bulk solution of 24.6% w/w lanreotide base. Each syringe contains: LANREOTIDE ACETATE LANREOTIDE ACETATE LANREOTIDE ACETATE 60 mg/0.2 mL 90 mg/0.3 mL 120 mg/0.5 mL Lanreotide acetate 74.9 mg 108.2 mg 141.5 mg Acetic Acid q.s. q.s. q.s. Water for injection 196.8 mg 284.5 mg 372.1 mg Total Weight 273.9 mg 395.9 mg 517.8 mg Lanreotide acetate is a synthetic cyclical octapeptide analog of the natural hormone, somatostatin. Lanreotide acetate is chemically known as [cyclo S-S]-3-(2-naphthyl)-D-alanyl-L-cysteinyl-L- tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, acetate salt. Its molecular weight is 1096.34 (base) and its amino acid sequence is: The Lanreotide Injection in the prefilled syringe is a white to pale yellow, semi-solid formulation. Lanreotide structure

By Generic Name

Drugs with the same generic name (different brands)

LANREOTIDE ACETATE LANREOTIDE ACETATE
60 mg/0.2 ml Injection
EXELAN PHARMACEUTICALS, INC. FDA Rx Only

Lanreotide Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). Lanreotide Injection is available as sterile, ready-to-use, single-dose prefilled syringes containing lanreotide acetate supersaturated bulk solution of 24.6% w/w lanreotide base. Each syringe contains: LANREOTIDE ACETATE LANREOTIDE ACETATE LANREOTIDE ACETATE 60 mg/0.2 mL 90 mg/0.3 mL 120 mg/0.5 mL Lanreotide acetate 74.9 mg 108.2 mg 141.5 mg Acetic Acid q.s. q.s. q.s. Water for injection 196.8 mg 284.5 mg 372.1 mg Total Weight 273.9 mg 395.9 mg 517.8 mg Lanreotide acetate is a synthetic cyclical octapeptide analog of the natural hormone, somatostatin. Lanreotide acetate is chemically known as [cyclo S-S]-3-(2-naphthyl)-D-alanyl-L-cysteinyl-L- tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, acetate salt. Its molecular weight is 1096.34 (base) and its amino acid sequence is: The Lanreotide Injection in the prefilled syringe is a white to pale yellow, semi-solid formulation. Lanreotide structure

LANREOTIDE ACETATE LANREOTIDE ACETATE
60 mg/0.2 ml Injection
CIPLA USA INC. FDA Rx Only

Lanreotide Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). Lanreotide Injection is available as sterile, ready-to-use, single-dose prefilled syringes containing lanreotide acetate supersaturated bulk solution of 24.6% w/w lanreotide base. Each syringe contains: LANREOTIDE ACETATE LANREOTIDE ACETATE LANREOTIDE ACETATE 60 mg/0.2 mL 90 mg/0.3 mL 120 mg/0.5 mL Lanreotide acetate 74.9 mg 108.2 mg 141.5 mg Acetic Acid q.s. q.s. q.s. Water for injection 196.8 mg 284.5 mg 372.1 mg Total Weight 273.9 mg 395.9 mg 517.8 mg Lanreotide acetate is a synthetic cyclical octapeptide analog of the natural hormone, somatostatin. Lanreotide acetate is chemically known as [cyclo S-S]-3-(2-naphthyl)-D-alanyl-L-cysteinyl-L- tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, acetate salt. Its molecular weight is 1096.34 (base) and its amino acid sequence is: The Lanreotide Injection in the prefilled syringe is a white to pale yellow, semi-solid formulation. structure

SOMATULINE DEPOT LANREOTIDE ACETATE
IPSEN BIOPHARMACEUTICALS, INC. FDA Rx Only

SOMATULINE DEPOT (lanreotide) Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). SOMATULINE DEPOT is available as sterile, ready-to-use, single-dose prefilled syringes containing lanreotide acetate supersaturated bulk solution of 24.6% w/w lanreotide base. Each syringe contains: SOMATULINE DEPOT 60 mg/0.2 mL SOMATULINE DEPOT 90 mg/0.3 mL SOMATULINE DEPOT 120 mg/0.5 mL Lanreotide acetate 77.9 mg 113.6 mg 149.4 mg Acetic Acid q.s. q.s. q.s. Water for injection 186.6 mg 272.3 mg 357.8 mg Total Weight 266 mg 388 mg 510 mg Lanreotide acetate is a synthetic cyclical octapeptide analog of the natural hormone, somatostatin. Lanreotide acetate is chemically known as [cyclo S-S]-3-(2-naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, acetate salt. Its molecular weight is 1096.34 (base) and its amino acid sequence is: The SOMATULINE DEPOT in the prefilled syringe is a white to pale yellow, semi-solid formulation. Chemical Structure

By Substance

Drugs sharing the same substance name

LANREOTIDE ACETATE LANREOTIDE ACETATE
60 mg/0.2 ml Injection
CIPLA USA INC. FDA Rx Only

Lanreotide Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). Lanreotide Injection is available as sterile, ready-to-use, single-dose prefilled syringes containing lanreotide acetate supersaturated bulk solution of 24.6% w/w lanreotide base. Each syringe contains: LANREOTIDE ACETATE LANREOTIDE ACETATE LANREOTIDE ACETATE 60 mg/0.2 mL 90 mg/0.3 mL 120 mg/0.5 mL Lanreotide acetate 74.9 mg 108.2 mg 141.5 mg Acetic Acid q.s. q.s. q.s. Water for injection 196.8 mg 284.5 mg 372.1 mg Total Weight 273.9 mg 395.9 mg 517.8 mg Lanreotide acetate is a synthetic cyclical octapeptide analog of the natural hormone, somatostatin. Lanreotide acetate is chemically known as [cyclo S-S]-3-(2-naphthyl)-D-alanyl-L-cysteinyl-L- tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, acetate salt. Its molecular weight is 1096.34 (base) and its amino acid sequence is: The Lanreotide Injection in the prefilled syringe is a white to pale yellow, semi-solid formulation. structure

LANREOTIDE ACETATE LANREOTIDE ACETATE
60 mg/0.2 ml Injection
EXELAN PHARMACEUTICALS, INC. FDA Rx Only

Lanreotide Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). Lanreotide Injection is available as sterile, ready-to-use, single-dose prefilled syringes containing lanreotide acetate supersaturated bulk solution of 24.6% w/w lanreotide base. Each syringe contains: LANREOTIDE ACETATE LANREOTIDE ACETATE LANREOTIDE ACETATE 60 mg/0.2 mL 90 mg/0.3 mL 120 mg/0.5 mL Lanreotide acetate 74.9 mg 108.2 mg 141.5 mg Acetic Acid q.s. q.s. q.s. Water for injection 196.8 mg 284.5 mg 372.1 mg Total Weight 273.9 mg 395.9 mg 517.8 mg Lanreotide acetate is a synthetic cyclical octapeptide analog of the natural hormone, somatostatin. Lanreotide acetate is chemically known as [cyclo S-S]-3-(2-naphthyl)-D-alanyl-L-cysteinyl-L- tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, acetate salt. Its molecular weight is 1096.34 (base) and its amino acid sequence is: The Lanreotide Injection in the prefilled syringe is a white to pale yellow, semi-solid formulation. Lanreotide structure

SOMATULINE DEPOT LANREOTIDE ACETATE
IPSEN BIOPHARMACEUTICALS, INC. FDA Rx Only

SOMATULINE DEPOT (lanreotide) Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). SOMATULINE DEPOT is available as sterile, ready-to-use, single-dose prefilled syringes containing lanreotide acetate supersaturated bulk solution of 24.6% w/w lanreotide base. Each syringe contains: SOMATULINE DEPOT 60 mg/0.2 mL SOMATULINE DEPOT 90 mg/0.3 mL SOMATULINE DEPOT 120 mg/0.5 mL Lanreotide acetate 77.9 mg 113.6 mg 149.4 mg Acetic Acid q.s. q.s. q.s. Water for injection 186.6 mg 272.3 mg 357.8 mg Total Weight 266 mg 388 mg 510 mg Lanreotide acetate is a synthetic cyclical octapeptide analog of the natural hormone, somatostatin. Lanreotide acetate is chemically known as [cyclo S-S]-3-(2-naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, acetate salt. Its molecular weight is 1096.34 (base) and its amino acid sequence is: The SOMATULINE DEPOT in the prefilled syringe is a white to pale yellow, semi-solid formulation. Chemical Structure

← Back to LANREOTIDE ACETATE